Other Markets
03-29-2010 |
19:27 hs.
The European Medicines Agency recommended withdrawal of several batches of Sanofi-Aventis SA and Bristol Myers Squibb Co. blockbuster drug, Plavix (Clopidogrel) that were manufactured by Acino Holding AG at a factory in India due to quality concerns.
Two-year legal battle
03-26-2010 |
14:57 hs.
06-18-2009 |
15:32 hs.
Novartis AG generic unit, Sandoz, announced launching in Denmark of generic version of AstraZeneca Plc. Blockbuster Nexium (Esomeprazole) at the same time assured that they have marketing approval for markets such as Ireland, Austria,. Hungary, Estonia, Latvia, Lituania, Finland, Portugal and Eslovenia.
12-01-2008 |
17:53 hs.
MRSA drug
11-13-2008 |
08:43 hs.
The Swiss agency for therapeutic products, Swissmedic, approved Zevtera (ceftobiprole medocaril) for the treatment of complicated skin and soft tissue infections, including diabetic foot infections which have not spread to the bone. Basilea is collaborating with Cilag, a Johnson & Johnson Co unit, to develop the antibiotic. Cilag will sell the drug in Switzerland.
10-31-2008 |
13:27 hs.
Factor Xa drug
10-31-2008 |
13:22 hs.
Rasilez HCT: Rasilez/Tekturna + diuretic
10-30-2008 |
09:05 hs.
10-02-2008 |
10:44 hs.
09-19-2008 |
12:18 hs.
09-19-2008 |
12:10 hs.
All-share deal
09-18-2008 |
11:09 hs.
09-17-2008 |
10:34 hs.
First country to market blood-thinning pill
09-16-2008 |
10:25 hs.
Germany´s Bayer AG announced it has won approval in Canada for its experimental blood-thinning pill Xarelto (rivaroxaban) for the prevention of blood clots after knee- or hip-replacement surgery. Partner-in-development is U.S.´s Johnson & Johnson.
09-05-2008 |
08:41 hs.
09-01-2008 |
12:32 hs.
08-04-2008 |
16:24 hs.
07-23-2008 |
13:03 hs.
Australian drugmaker Progen Pharma has decided to scrap the development of its key PI-88 liver cancer drug after losing out to Bayer AG in the race to come up with an effective liver cancer treatment. Progen shares hit 5-year low
07-18-2008 |
15:26 hs.
06-30-2008 |
15:02 hs.
